Publicacións en colaboración con investigadores/as de Hospital Alemão Oswaldo Cruz (17)

2024

  1. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

    Microorganisms, Vol. 12, Núm. 4

2022

  1. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  2. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Pathogens, Vol. 11, Núm. 10

2020

  1. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

2019

  1. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial

    Vaccine, Vol. 37, Núm. 35, pp. 4858-4863

  2. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study

    BMJ Open, Vol. 9, Núm. 5

2018

  1. Incidence of and associated factors for bacterial colonization of intravenous catheters removed from dogs in response to clinical complications

    Journal of Veterinary Internal Medicine, Vol. 32, Núm. 3, pp. 1084-1091

2017

  1. Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial

    Vaccine, Vol. 35, Núm. 16, pp. 2052-2059

  2. Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial

    Vaccine, Vol. 35, Núm. 28, pp. 3548-3557

2014

  1. Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

    AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862

2008

  1. Ascertaining late-life depressive symptoms in Europe: An evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project

    International Journal of Methods in Psychiatric Research, Vol. 17, Núm. 1, pp. 12-29

  2. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: A HuGE-GSEC review

    Genetics in Medicine, Vol. 10, Núm. 6, pp. 369-384

2007

  1. Dolor torácico y eosinofilia periférica

    Revista Clinica Espanola, Vol. 207, Núm. 2, pp. 93-94

  2. Prevalence of depressive symptoms and syndromes in later life in ten European countries: The SHARE study

    British Journal of Psychiatry, Vol. 191, Núm. NOV., pp. 393-401

1997

  1. Identification of Transcribed Sequences (ESTs) in the Trypanosoma cruzi Genome Project

    Memorias do Instituto Oswaldo Cruz, Vol. 92, Núm. 6, pp. 863-866

  2. Towards the Physical Map of the Trypanosoma cruzi Nuclear Genome: Construction of YAC and BAC Libraries of the Reference Clone T. cruzi CL-Brener

    Memorias do Instituto Oswaldo Cruz, Vol. 92, Núm. 6, pp. 843-852

1995

  1. Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi Genome Project

    Molecular and Biochemical Parasitology, Vol. 71, Núm. 2, pp. 273-278